Maxcyte (MXCT) Other financing activities (2020 - 2026)

Maxcyte (MXCT) has 7 years of Other financing activities data on file, last reported at $5000.0 in Q1 2026.

• On a quarterly basis, Other financing activities fell 98.69% year-over-year to $5000.0 in Q1 2026; TTM through Mar 2026 was -$154000.0, a 210.79% decrease from a year earlier, with the FY2025 full-year figure at $224000.0, down 51.2% from the prior year.
• Other financing activities for Q1 2026 stood at $5000.0, up from -$193000.0 in the prior quarter.
• Over the last five years, Other financing activities for MXCT reached as high as $1.5 million in Q1 2023 and fell as low as -$1.4 million in Q4 2023.
• Historically, Other financing activities has averaged $226176.5 across 5 years, with a median of $283000.0 in 2025.
• Across the five-year window, Other financing activities jumped 523.56% in 2022 and plunged 2494.59% in 2024, its largest moves.
• Year by year, Other financing activities stood at $1.2 million in 2022, then plunged by 212.69% to -$1.4 million in 2023, then soared by 114.05% to $194000.0 in 2024, then sank by 199.48% to -$193000.0 in 2025, then jumped by 102.59% to $5000.0 in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $5000.0 in Q1 2026, -$193000.0 in Q4 2025, and $283000.0 in Q3 2025.